Syra Health Reports Q3 Revenue Growth and Reduced Net Loss

Reuters

2025/11/12

Syra Health Reports Q3 Revenue Growth and Reduced Net Loss

Syra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2582795233"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582795233\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582795233?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 20:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582795233","market":"nz","top_or_hot":-1,"title":"Syra Health Reports Q3 Revenue Growth and Reduced Net Loss","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/SYRA\">Syra Health Corp.</a> announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its <a href=\"https://laohu8.com/S/PHIC\">Population Health</a> business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Syra Health Reports Q3 Revenue Growth and Reduced Net Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSyra Health Reports Q3 Revenue Growth and Reduced Net Loss\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-11-12 20:55</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/SYRA\">Syra Health Corp.</a> announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its <a href=\"https://laohu8.com/S/PHIC\">Population Health</a> business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYRA","symbol_name":"Syra Health Corp.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL2pP1gt:1","article_id":"2582795233","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582795233","pubTimestamp":1762952134,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Syra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to , compared to  in Q3 2024, due to improved operational efficiency. Earnings per share improved to  in Q3 2025 from  in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SYRA":"Syra Health Corp.","BK4196":"保健护理服务"},"translate_title":"Syra Health报告第三季度收入增长并减少净亏损","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRA":0.9},"content_text":"Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    \n\nSyra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}